Member Info for miti1000

Thanks for arranging that, Chacha.

From recent interviews , its clear that SCI -MX is bedding in nicely and was profitable from month 1 .So that's a big tick , hopefully the excellent CFO, will be more inclined to call it acccretive now and rise guidance for the full year. Sandy called this his 'best ever acquistion'. That's a huge statement and I'm expecting big things now its bedded down.

The 2 questions are clearly supply chain issues and the effect of Whey prices on margins.

Quite honestly, with Sandy's experience over the years, I'd expect him to have supply chain issues well under his control and whey prices have been high for a while so hopefully he can mitigate going forward.
Sandy has been very bullish on prospects and I would hope he can raise guidance next week and actually , I believe, guidance from Berenberg was conservative at just about 10% revenue increase for the current year. Time to start delivering , Sandy, and show you are well ahead of the curve !!
I'll ask a few questions at the presentation but if you can get prison contracts for vaping, you must be first in line for any NHS vaping ones. Also , lets hope Millions & Millions is getting some serious traction at the retailers.

Roll on next week.

Chacha,

Will you be doing a presentation at the interim results next week which we can listen to and ask questions ?

Thanks.

Well this rights issue is proving to a bit of a disaster. The ex rights price was 294 .Now its 260p ..that's simply an 11% haircut for shareholders.

webcast for presentation at 10.am...

webcasting.brrmedia.co.uk/broadcast/60d30f5c55a96337f0d9c198

The addition of Sainsbury's to the 88vape list of retailers is also very promising.

Big speculation via Betaville.

Briiliant research, thanks. That would tie in with exactly with how Supreme has bought assets previously at knockdown prices and entered them it its supply chain. Battle bites for example.

Well, its certainly what I was hoping Sandy would do and he's certainly delivering acquistions and bolt ons. Just a pity no mention of what the price is or whether its will earnings enhancing.Thats probabaly led to the muted reaction . Nevertheless the ROCE by Supreme has been nothing short of spectacular to date so I'm sure it will be more of the same.
Roll on the results.

Anyone been allocated their shares yet in their account ?

Celaton looks way too small for ADVT but probably the right size for SWC . Company accounts only appear to show revenue of 4mill ?

Shares been credited btw at HL at least.

Fantastic coverage today by a well known value investor. I presume their subscribers will get it tomorrow. Very in depth and huge positive hence the mark up today.
The only thing I would add to it is Supreme(Sandy) is very acquisiitive with incredible ROCE which will be immediately accretive to earnings so I would hope we will see a few of those in the current year with such a strong balance sheet.

Many thanks ,chacha .
I've also asked Equity Development who do some great research and presentations (recently did one on UPGS for example) to get in touch in this regard.

Chacha,

Could you please make sure that you give a live results presentation to retail investors so it will give us a chance to ask questions and listen to your views along with your team.

Companies , such as PI World, investormeet etc all do this for companies and I'm sure would be delighted to have Supreme do such a presentation.

The update is good but I was clearly expecting more. The broker forecast on IPO was too punchy but this years forecasts look way more conservative.
Looking ahead we have vitamins launch at anytime and hopefully a high profile launch.

No, that's wrong think about. She says she wants to help companies make the move from 200-300million to 1billion.So that their target size of acqusition.
Also they raised around 130million so that with vendor rollover and a raise will get them their target of 200-300million.
I'm not investing 500k without being pretty sure of the acquisition size.

I would prefer her to go for a uk based acquistion in the tech space rather a foreign one. Either way, I expect the market to love whatever her choice is though given her track record.

No timeframes sadly Normally, the limit is around 2years otherwise they retrun the money. But clearly, Vin Murria , will find something well before then having invested her time and money .
I'm building a big position around these levels in anticpation of a deal but wouldn't be a shock if we had to wait till end of the year. Fingers crossed its earlier.

I'd imagine any seller of a 250mill market cap tech company would love to have her taking them to IPO.

Totally agree, my biggest holding.
The forecast of 510million for y/e2022 also seem light to me .Next year will probably include at least 50million from Deka and assumes only another 20million growth. But the biggest division, medical , should have picked up in 2022 as hospitals open up and EV has surely got to rise substantially as volex has all the main players, Tesla, VW and Ford probably signed up.

Also no doubt a few more acquisitions this year , as alluded to. I'm hoping for closer to 550million .

Long term hold . Absolutely top quality imo.

Looking at the broker forecasts, Berenberg are going for y/e 4/2023 of 139million revenue and 23.50 mill ebitda up from 122 mill and 18.80 for the year just passed 3/2021 , I just cant see those not being smashed.
The founder is aggressive in accretive, cheap acquisitions and has low capex. Moreover , he doesn't just want to be a 3rd party supplier once he has scale .he wants to manufacturer in house to improve margins.
I'm hoping for a forecast busting trading statement this month.
This is just a growth company and deserves a premium rating . On that basis , I'm about to add another 50-100k shares in a few minutes.

Can't see it falling to those levels...I'm expecting at least a 5%-8% premium today to the prices I've quoted. With the reopening set for next week and June, I think the outlook over the next few months for SSPG will be for 450 now its repaired its balanced sheet.